Loading
Latest filing published 27 Dec 2021 for Vincerx Pharma, Inc., €26k. Read the official filing
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Sooin Hwang is a declared insider of Vincerx Pharma, Inc., with filings sourced from SEC (Form 4). In total, 2 filings cover trades dated from 30 June 2021 to 23 December 2021.
Purchases make up the whole of the open-market record (2 purchases, €32k). Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The newest entry dates from 27 December 2021: an open-market purchase of €26k, in Vincerx Pharma, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations